MRECIST Criteria Response to Pretransplant Transarterial Chemoembolization (TACE) is Predictive of Improved Survival for Patients With HCV Undergoing Liver Transplantation for Hepatocellular Carcinoma (HCC)

被引:0
|
作者
Clark, Paul J.
Heimbach, Julie K.
Rosen, Charles B.
Sanchez, William
Gores, Gregory J.
Muir, Andrew J.
Charlton, Michael R.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S1005 / S1006
页数:2
相关论文
共 50 条
  • [1] Comparison of two techniques of transarterial chemoembolization (TACE) before liver transplantation (LT) for hepatocellular carcinoma (HCC)
    Dharancy, S
    Boitard, J
    Decaens, T
    Duvoux, C
    Declerck, N
    Truant, S
    Canva, VR
    Sergent, G
    Bresson-Hadni, S
    Meyer, C
    Gugenheim, J
    Durand, F
    Boillot, O
    Ernst, O
    Mathurin, P
    Pruvot, R
    HEPATOLOGY, 2005, 42 (04) : 332A - 333A
  • [2] Transarterial Chemoembolization (TACE) As a Bridging Therapy Prior to Liver Transplantation (LTX) in Patients with Hepatocellular Carcinoma (HCC): Do Patients Benefit ?
    Meister, Tobias
    Heinzow, Hauke
    Nass, Dominik
    Koehler, Michael
    Ullerich, Hansjoerg
    Domschke, Wolfram W.
    Domagk, Dirk
    GASTROENTEROLOGY, 2009, 136 (05) : A479 - A479
  • [3] Inflammatory Markers are Associated with Outcome in Patients with Unresectable Hepatocellular Carcinoma (HCC) undergoing Transarterial Chemoembolization (TACE)
    McNally, M. E.
    Martinez, A.
    Malhotra, L.
    Bloomston, M.
    Schmidt, C. R.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S33 - S33
  • [4] Sequential transarterial chemoembolization (TACE) followed by orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC) beyond the Milan criteria - A prospective study
    Moench, C
    Grebe, A
    Schuchmann, M
    Herber, S
    Pitton, MB
    Lohse, AW
    Galle, PR
    Otto, G
    JOURNAL OF HEPATOLOGY, 2004, 40 : 5 - 5
  • [5] Effect of transarterial Chemoembolization (TACE) on hepatocellular carcinoma (HCC) recurrence after liver transplantation: a single center experience
    Mokadem, H
    Salotti, J
    Richards, L
    Barakat, F
    Rose, S
    Behling, C
    Sirlin, C
    Alpert, E
    Mattrey, R
    Khanna, A
    Hart, M
    Hassanein, T
    GASTROENTEROLOGY, 2005, 128 (04) : A757 - A757
  • [6] mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization
    Moschouris, Hippocrates
    Malagari, Katerina
    Papadaki, Marina G.
    Kornezos, Ioannis
    Stamatiou, Konstantinos
    Anagnostopoulos, Antonios
    Chatzimichael, Katerina
    Kelekis, Nikolaos
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2014, 20 (02) : 136 - 142
  • [7] Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
    Lei Jianyong
    Zhong Jinjing
    Luo Yefang
    Yan Lunan
    Zhu Jinqiang
    Wang Wentao
    Li Bo
    Wen Tianfu
    Yang Jiaying
    ONCOTARGET, 2017, 8 (53) : 91328 - 91342
  • [8] Response To Transarterial Chemoembolization May Serve as Selection Criteria for Hepatocellular Carcinoma Liver Transplantation
    Lei, Jianyong
    Yan, Lunan
    Wang, Wentao
    TRANSPLANTATION, 2015, 99 : 240 - 241
  • [9] Thalidomide (Thal) tolerance in patients treated with transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC)
    Goldenberg, A
    Volm, M
    Hochster, H
    Muggia, F
    Rosen, R
    Teperman, L
    Morgan, G
    Schwartz, J
    Sung, M
    Wadler, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 376S - 376S
  • [10] Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma
    Bhat, M.
    Hassanain, M.
    Simoneau, E.
    Tzimas, G. N.
    Chaudhury, P.
    Deschenes, M.
    Valenti, D.
    Ghali, P.
    Wong, P.
    Cabrera, T.
    Barkun, J.
    Tchervenkov, J. I.
    Metrakos, P.
    CURRENT ONCOLOGY, 2013, 20 (05) : 265 - 272